Noninvasive markers of endometriosis and their dynamics during hormone therapy
OA: bronze
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study identified noninvasive biomarkers for endometriosis and tracked their changes over time during hormone therapy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (14)
- Angiogenic factors in endometriosis via openalex
- Apoptosis and endometriosis via openalex
- A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis via openalex
- Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high-dose medroxyprogesterone acetate via openalex
- Endometrial-peritoneal interactions during endometriotic lesion establishment via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Evaluation of endometrial biomarkers for semi-invasive diagnosis of endometriosis via openalex
- Serum CA-125 in the diagnosis of endometriosis via openalex
- Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis via openalex
- The role of cytokines in endometriosis via openalex
- W2117842006 via openalex
- W1994088961 via openalex
- W2135721067 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK